Publications
Back to News and Media

Validation of a Novel Type II HER2 Inhibitor Through Preclinical Studies Across Various Cancer Models (AACR 2024 Poster)

Publications
This is some text inside of a div block.
April 8, 2024

Media Contacts

Related announcements

View All
View All
March 2, 2026

Iambic to Participate in March Investor Conferences

Read more
March 2, 2026

Iambic to Participate in March Investor Conferences

Read more
February 9, 2026

Iambic Announces Collaboration with Takeda to Advance AI-Driven Design of Small Molecules

Read more
February 9, 2026

Iambic Announces Collaboration with Takeda to Advance AI-Driven Design of Small Molecules

Read more
December 16, 2025

Iambic Therapeutics to present at the 44th annual J.P. Morgan healthcare conference

Read more
December 16, 2025

Iambic Therapeutics to present at the 44th annual J.P. Morgan healthcare conference

Read more